In 1981, UCLA physicians reported the very first cases of what was described as “newly acquired immunodeficiency” — the disease entity we now know as AIDS. That discovery — and the subsequent exponential explosion of AIDS cases in Los Angeles, around the country, and around the world — led to the formation of the world-acclaimed UCLA AIDS Institute in 1992.

The AIDS Institute provides a unique, multidisciplinary environment for researchers who are assailing HIV from a dozen disciplines and directions. Institute members include faculty working in virology and immunology, genetics, cancer, neurology, ophthalmology, epidemiology, social science, public health, nursing, and disease prevention. Their studies are carried out in several locations on the UCLA Westwood campus, in addition to community settings, major medical centers in greater Los Angeles, and scores of international locations including India, China, Brazil, and sub-Saharan Africa.

The UCLA AIDS Institute receives most of its infrastructure support from the Centers for AIDS Research (CFAR) program of the National Institutes of Health. The UCLA CFAR was established in 1988 and is currently one of 20 CFARs across the United States. The mission of the UCLA CFAR is to create synergy among diverse research disciplines that result in significant breakthroughs in understanding, preventing and treating HIV infection.

The HIV/AIDS work carried out by Dr. Rotheram and CHIPTS would not be possible without the support of the UCLA AIDS Institute and CFAR.